As of November 2024 Alnylam Pharmaceuticals has 124.91M shares outstanding, a increase of 2.64% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 124.91M | 2.64% |
2022 | 121.69M | 2.73% |
2021 | 118.45M | 3.01% |
2020 | 114.99M | - |